Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from QuantumPharm, Inc. ( (HK:2228) ).
XtalPi Holdings Limited has announced a change in senior management as CFO Mr. Tam Man Hong transitions to the role of Hong Kong and International Development Adviser effective January 2026. This strategic shift will allow Mr. Tam to focus on the company’s business development in Hong Kong and international markets, including contributing to sustainable growth, mergers and acquisitions, and establishing an incubation ecosystem. The announcement is positioned to strengthen XtalPi’s regional and global presence while ensuring consistent leadership guidance. Details regarding the appointment of the next CFO will be announced in due course.
The most recent analyst rating on (HK:2228) stock is a Hold with a HK$9.50 price target. To see the full list of analyst forecasts on QuantumPharm, Inc. stock, see the HK:2228 Stock Forecast page.
More about QuantumPharm, Inc.
XtalPi Holdings Limited operates within the pharmaceutical and biotechnological industry, providing innovative solutions that bridge artificial intelligence and molecular dynamics to accelerate drug discovery and development. The company and its subsidiaries focus on catering to international markets, encompassing cutting-edge technology and collaboration to enhance scientific advancement.
Average Trading Volume: 103,505,958
Technical Sentiment Signal: Hold
Current Market Cap: HK$39.27B
For detailed information about 2228 stock, go to TipRanks’ Stock Analysis page.